New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.
A bioethicist argues that the government has the right to restrict or override intellectual property rights in response to a national emergency only when specific criteria are met.
The Model State Emergency Health Powers Act proposes state legislation that should be enacted to ensure an adequate and coordinated response to public health emergencies.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.